NCT07517640 2026-04-08
Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Tianjin Medical University Cancer Institute and Hospital
Sun Yat-sen University
Sichuan University
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo